col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


71 Results       Page 1

 [1] 
Ferrata Storti Foundation: Haematologica
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―11 Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes Ángel Serna, Víctor Navarro, Gloria Iacoboni, Laia López, Juan-Manuel Sancho, Eva González-Barca, et al. (+14)
2 [GO] 2024―Jun―06 Reply to the Comment on Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry Tommaso Francesco Aiello, Carolina Garcia-Vidal
3 [GO] 2024―May―23 Comment to “Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry” Guangting Zeng, Jing Liu
4 [GO] 2024―May―23 Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control Annalisa Ruggeri, Francesco Corrado, Antonio Voza, Lee-Jen Wei, Gloria Catalano, Carmine Liberatore, et al. (+16)
5 [GO] 2024―Apr―24 Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia Gordon J. Ruan, Xiaosheng Wu, Kimberly A. Gwin, Michelle K Manske, Jithma P. Abeykoon, Vaishali Bhardwaj, et al. (+6)
6 [GO] 2024―Apr―04 Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Jens Van Praet, et al. (+103)
7 [GO] 2024―Feb―22 Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses Mehmet H. Kocoglu, Paul G. Richardson, Clifton C. Mo, Aaron P. Rapoport, Djordje Atanackovic
8 [GO] 2024―Jan―25 Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Y Chen, et al. (+18)
9 [GO] 2023―Dec―07 Sickle cell disease, pregnancy, and COVID-19 in France: <i>plus ça change</i> Lydia H. Pecker, Jerome Federspiel
10 [GO] 2023―Oct―19 A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates. Laure Joseph, Gonzalo De Luna, Emmanuelle Bernit, Pierre Cougoul, Aline Santin, Benoit Faucher, et al. (+7)
11 [GO] 2023―Aug―30 Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia Hanna M. Ingelman-Sundberg, Lisa Blixt, David Wullimann, Jinghua Wu, Yu Gao, Katie Healy, et al. (+14)
12 [GO] 2023―Aug―16 SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria Morag Griffin, Dirk-Jan Eikema, Inge Verheggen, Alexander Kulagin, Jennifer M-L. Tjon, Bruno Fattizzo, et al. (+18)
13 [GO] 2023―Aug―03 Impaired T-cell response to mRNA vaccination heralds risk of COVID-19 in long-term allogeneic hematopoietic stem cell transplantation survivors Sigrun Einarsdottir, Jesper Waldenström, Andreas Törnell, Johan Ringlander, Joakim B. Stenbäck, Sebastian Malmström, et al. (+3)
14 [GO] 2023―Jun―22 Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients Justin C. Laracy, Judy Yan, Samantha N. Steiger, Carrie A. Tan, Nina Cohen, Elizabeth V. Robilotti, et al. (+11)
15 [GO] 2023―Mar―23 Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients Marco Capecchi, Pasqualina De Leo, Maria Abbattista, Ilaria Mancini, Pasquale Agosti, Marina Biganzoli, et al. (+11)
16 [GO] 2023―Feb―16 Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic Masatoshi Sakurai, Yasunori Kogure, Kota Mizuno, Eri Matsuki, Keisuke Kataoka
17 [GO] 2023―Jan―26 COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination Short title: COVID-19 thromboembolism Hannah Stevens, Sergio Ruiz-Carmona, Karlheinz Peter, James McFadyen
18 [GO] 2022―Dec―29 Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience Silvia Maria Trisolini, Saveria Capria, Andrea Artoni, Ilaria Mancini, Mario Biglietto, Giuseppe Gentile, et al. (+2)
19 [GO] 2022―Dec―15 Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19 Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Sander M.J. Van Kuijk, Joop P. Aendekerk, Renée Ysermans, Daan P.C. Van Doorn, et al. (+9)
20 [GO] 2022―Dec―07 Terrific T cells for SARS-CoV-2 Stephen Gottschalk
21 [GO] 2022―Nov―24 COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from Apidulcis study Gualtiero Palareti, Cristina Legnani, Daniela Poli, Walter Ageno, Vittorio Pengo, Sophie Testa, et al. (+2)
22 [GO] 2022―Nov―10 Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high risk patients Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, et al. (+12)
23 [GO] 2022―Nov―10 Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, et al. (+5)
24 [GO] 2022―Sep―29 Comment on: Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis Yacong Shao, Yongming Zhou
25 [GO] 2022―Sep―15 Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors Chang Kyung Kang, Baekgyu Choi, Sugyeong Kim, Choong Hyun Sun, Soon Ho Yoon, Kyukwang Kim, et al. (+18)
26 [GO] 2022―Aug―11 Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B cell depletion Ariela Noy, Santosha A. Vardhana
27 [GO] 2022―Jun―23 SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia Sibylle C. Mellinghoff, Leonie Mayer, Sandra Robrecht, Leonie M. Weskamm, Christine Dahlke, Henning Gruell, et al. (+11)
28 [GO] 2022―Jun―23 COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic haematopoietic stem cell transplantation Hanna Grauers Wiktorin, Sigrun Einarsdottir, Andreas Törnell, Mohammad Arabpour, Nuttida Issdisai, Jesper Waldenström4, et al. (+5)
29 [GO] 2022―May―26 The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARS-CoV2 infection and multisystem inflammatory syndrome in children Tarun Aurora, Noel Joseph, Senthil Velan Bhoopalan, Miguela A Caniza, Tim Flerlage, Saad Ghafoor, et al. (+8)
30 [GO] 2022―May―12 COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA) Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, Klára Piukovics, Marcio Nucci, Alberto López-García, et al. (+86)
31 [GO] 2022―May―12 A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis José Manuel Soria, Sergi Mojal, Angel Martinez-Perez, Francisco René Acosta, Sonia López, Sara Miqueleiz, et al. (+7)
32 [GO] 2022―May―05 Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study Gaetano Giuffrida, Uros Markovic, Annalisa Condorelli, Marianna Calagna, Stephanie Grasso, Andrea Duminuco, et al. (+4)
33 [GO] 2022―Apr―21 COVID-19 Infection in acute lymphoblastic leukemia over 15 months of the pandemic. A CAMPUS ALL report. Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, Fabio Giglio, Mario Annunziata, Antonio Curti, et al. (+23)
34 [GO] 2022―Mar―31 Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis Lorenzo Loffredo, Augusto Di Castelnuovo, Giovanni Alfonso Chiariello, Pasquale Pignatelli, Francesco Violi
35 [GO] 2022―Mar―17 Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19 Carolina Garcia-Vidal, Pedro Puerta-Alcalde, Aina Mateu, Genoveva Cuesta-Chasco, Fernanda Meira, Carlos Lopera, et al. (+15)
36 [GO] 2022―Mar―03 Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic haematopoietic stem cell transplantation Sigrun Einarsdottir, Anna Martner, Malin Nicklasson, Hanna Grauers Wiktorin, Mohammad Arabpour, Andreas Törnell, et al. (+8)
37 [GO] 2022―Feb―17 Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein Manuela De Michele, Paola Piscopo, Alessio Crestini, Roberto Rivabene, Giulia D’Amati, Martina Leopizzi, et al. (+10)
38 [GO] 2022―Jan―20 BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes Sultan Abdul-Jawad, Richard Beatson, Thomas Lechmere, Rosalind Graham, Thanussuyah Alaguthurai, Carl Graham, et al. (+5)
39 [GO] 2022―Jan―20 Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines Stephan Michalik, Florian Siegerist, Raghavendra Palankar, Kati Franzke, Maximilian Schindler, Alexander Reder, et al. (+11)
40 [GO] 2021―Dec―30 Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination Giovanni Caocci, Daniela Fanni, Mariagrazia Porru, Marianna Greco, Sonia Nemolato, Davide Firinu, et al. (+3)
41 [GO] 2021―Dec―16 Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis Nico Gagelmann, Francesco Passamonti, Christine Wolschke, Radwan Massoud, Christian Niederwieser, Raissa Adjallé, et al. (+3)
42 [GO] 2021―Nov―18 When timing is more important than quantity in COVID-19 vaccination Raul Cordoba
43 [GO] 2021―Nov―04 Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study Nicola Sgherza, Paola Curci, Rita Rizzi, Vanda Strafella, Daniela Di Gennaro, Angelantonio Vitucci, et al. (+6)
44 [GO] 2021―Oct―21 SARS-CoV-2 infection in aplastic anaemia Daniele Avenoso, Judith C W Marsh, Victoria Potter, Antonio Pagliuca, Simon Slade, Fiona Dignan, et al. (+9)
45 [GO] 2021―Oct―07 Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination Roberta Misasi, Antonella Capozzi, Gloria Riitano, Serena Recalchi, Valeria Manganelli, Vincenzo Mattei, et al. (+5)
46 [GO] 2021―Sep―03 Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdO×1 nCov-19 vaccine Mariangela Scavone, Bianca Clerici, Simone Birocchi, Tatiana Mencarini, Mariagrazia Calogiuri, Claudia Ghali, et al. (+5)
47 [GO] 2021―Aug―26 Immune thrombocytopenia following vaccination during the COVID-19 pandemic Philip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, Chee Wee Tan, Anoop Enjeti, Vivien Mun Yee Chen, et al. (+4)
48 [GO] 2021―Aug―12 Immune-mediated thrombotic thrombocytopenic purpura following Pfizer-BioNTech COVID-19 vaccine Gaetano Giuffrida, Annalisa Condorelli, Mary Ann Di Giorgio, Uros Markovic, Roberta Sciortino, Daniela Nicolosi, Francesco Di Raimondo
49 [GO] 2021―Aug―11 Thrombotic thrombocytopenic purpura and other immune mediated blood disorders following SARS-CoV-2 Vaccination Pier Mannuccio Mannucci
50 [GO] 2021―Aug―05 Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - A fifteen hospital observational study in the Bronx, New York Wouter S. Hoogenboom, Roman Fleysher, Selvin Soby, Parsa Mirhaji, William B. Mitchell, Kerry A. Morrone, et al. (+2)
51 [GO] 2021―Jul―22 Complement dysregulation is associated with severe COVID-19 illness Jia Yu, Gloria F. Gerber, Hang Chen, Xuan Yuan, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky
52 [GO] 2021―Jul―15 Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman Daniela P. Mendes-de-Almeida, Remy Martins-Gonçalves, Renata Morato-Santos, Gustavo Adolpho C. De Carvalho, Silas A. Martins, Lohanna Palhinha, et al. (+6)
53 [GO] 2021―May―20 A new enemy is emerging in the fight against the SARS-CoV-2 pandemic Francesco Rodeghiero, Carlo L. Balduini
54 [GO] 2021―May―20 Antibody-mediated procoagulant platelets in SARS-CoV-2- vaccination associated immune thrombotic thrombocytopenia Karina Althaus, Peter Möller, Günalp Uzun, Anurag Singh, Annika Beck, Martin Bettag, et al. (+29)
55 [GO] 2021―May―13 Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation? Valentine Brousse, Laurent Holvoet, Rémi Pescarmona, Sebastien Viel, Magali Perret, Benoit Visseaux, et al. (+6)
56 [GO] 2021―Apr―08 Circulating histones play a central role in COVID-19-associated coagulopathy and mortality Rebecca J. Shaw, Simon T. Abrams, James Austin, Joseph M. Taylor, Steven Lane, Tina Dutt, et al. (+8)
57 [GO] 2021―Mar―11 Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection Stefania Fiorcari, Claudio Giacinto Atene, Rossana Maffei, Giulia Debbia, Leonardo Potenza, Mario Luppi, Roberto Marasca
58 [GO] 2020―Dec―17 Immunologic characterization of COVID-19 patients with hematological cancer Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Díaz De Cerio, Susana Inogés, Manuel F. Landecho, et al. (+21)
59 [GO] 2020―Dec―01 COVID-19: risk of infection is high, independently of ABO blood group Willy Albert Flegel
60 [GO] 2020―Oct―29 COVID-19 and sickle cell disease Laurel A. Menapace, Swee Lay Thein
61 [GO] 2020―Oct―05 SARS-CoV-2 severity in african americans - A role for Duffy Null? Robert P. Hebbel, Gregory M. Vercellotti
62 [GO] 2020―Sep―16 Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients Paul Telfer, Josu De la Fuente, Mamta Sohal, Ralph Brown, Perla Eleftheriou, Noémi Roy, et al. (+26)
63 [GO] 2020―Sep―16 No evidence of hemoglobin damage by SARS-CoV-2 infection Anthony W. DeMartino, Jason J. Rose, Matthew B. Amdahl, Matthew R. Dent, Faraaz A. Shah, William Bain, et al. (+4)
64 [GO] 2020―Aug―27 Hemostatic alterations in COVID-19 Flora Peyvandi, Andrea Artoni, Cristina Novembrino, Stefano Aliberti, Mauro Panigada, Marco Boscarino, et al. (+7)
65 [GO] 2020―Jul―30 Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, Gabriele Ihorst, Francesca Biavasco, Katharina Meckel, et al. (+11)
66 [GO] 2020―Jul―23 Perforin gene variant A91V in young patients with severe COVID-19. Oscar Cabrera-Marante, Edgard Rodríguez de Frías, Daniel E. Pleguezuelo, Luis M. Allende, Antonio Serrano, Rocío Laguna-Goya, et al. (+6)
67 [GO] 2020―Jul―23 Complement C5 inhibition in patients with COVID-19 - a promising target? Regis Peffault de Latour, Anne Bergeron, Etienne Lengline, Thibault Dupont, Armance Marchal, Lionel Galicier, et al. (+11)
68 [GO] 2020―Jul―23 Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial Cesare Perotti, Fausto Baldanti, Raffaele Bruno, Claudia Del Fante, Elena Seminari, Salvatore Casari, et al. (+11)
69 [GO] 2020―Jul―23 ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults Laurys Boudin, Frédéric Janvier, Olivier Bylicki, Fabien Dutasta
70 [GO] 2020―Jul―02 Dramatic presentation of acquired TTP associated with COVID-19 Marco Capecchi, Cristina Mocellin, Chiara Abbruzzese, Ilaria Mancini, Daniele Prati, Flora Peyvandi
71 [GO] 2020―Jun―11 COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital Subarna Chakravorty, Giselle Padmore-Payne, Fester Ike, Virginia Tshibangu, Charlotte Graham, David Rees, Sara Stuart-Smith
 [1] 

71 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec